Wissenschaftliche Arbeiten

Doç. Dr. Abdilkerim Oyman

32 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil

  1. Impact of HER2-Low Expression on Clinical Outcomes in Metastatic Breast Cancer Treated with CDK4/6 Inhibitors

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15051898 PMID 41827314 Frei zugänglicher VolltextQuelle: OpenAlex

  2. Clinicopathological Predictors of Axillary Pathological Complete Response and Its Prognostic Significance in Clinically Node-Positive (cN+), HER2-Positive Breast Cancer Following Neoadjuvant Therapy

    Medicina, 2026

    DOI 10.3390/medicina62010200 PMID 41597486 Frei zugänglicher VolltextQuelle: OpenAlex

  3. Meme Kanseri

    Akademisyen Kitabevi eBooks, 2026

    DOI 10.37609/akya.3852 Frei zugänglicher VolltextQuelle: OpenAlex

  4. Comparative Prognostic Value of Systemic Inflammation-Based Biomarkers in Advanced Non-Small Cell Lung Cancer Treated with First-Line Immunotherapy

    Biomedicines, 2026

    DOI 10.3390/biomedicines14081825 PMID 42652206 Frei zugänglicher VolltextQuelle: OpenAlex

  5. Prognostic Impact of the Lung Immune Prognostic Index in Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab

    Cancers, 2026

    DOI 10.3390/cancers18071170 PMID 41976392 Frei zugänglicher VolltextQuelle: OpenAlex

  6. Nadir Görülen Meme Kanseri Alt Tipleri

    Akademisyen Kitabevi eBooks, 2026

    DOI 10.37609/akya.3852.c2805 Quelle: ORCID

  7. Comparison of the efficacy of mFOLFOX-6 and mDCF regimens in the treatment of metastatic gastric cancer: a multicenter retrospective study

    Therapeutic Advances in Medical Oncology, 2025

    DOI 10.1177/17588359251368069 PMID 40900677 5 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  8. Long-Term Oncological Outcomes for Locally Advanced Rectal Cancer Patients with Pathological Complete Response After Neoadjuvant Chemoradiotherapy: A Turkish Oncology Group Study

    Cancer Investigation, 2025

    DOI 10.1080/07357907.2025.2595536 PMID 41347635 1 Zitation (Europe PMC) Quelle: OpenAlex

  9. Can Cytoreductive Nephrectomy Improve Outcomes of Nivolumab Treatment in Patients with Metastatic Clear-Cell Renal Carcinoma?

    Current Oncology, 2024

    DOI 10.3390/curroncol31090384 PMID 39330012 Frei zugänglicher VolltextQuelle: OpenAlex

  10. Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

    BMC Cancer, 2023

    DOI 10.1186/s12885-023-10609-8 PMID 36765293 18 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  11. Meme Kanseri

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1100 Frei zugänglicher VolltextQuelle: OpenAlex

  12. Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer

    Journal of Cancer Research and Therapeutics, 2022

    DOI 10.4103/jcrt.jcrt_1104_21 PMID 36510987 6 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  13. Real life experience of patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study

    Journal of Chemotherapy, 2022

    DOI 10.1080/1120009x.2022.2073159 PMID 35579894 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  14. Onkolojide Güncel Tedavi Yaklaşımları 1

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1606 Quelle: OpenAlex

  15. Psychological Impacts of COVID-19 Pandemic in Cancer Patients on Active Treatment

    2022

    DOI 10.2139/ssrn.4051677 Frei zugänglicher VolltextQuelle: ORCID

  16. The effect of preoperative prognostic nutritional index on outcome in glioblastoma multiforme patients

    Journal of Surgery and Medicine, 2022

    DOI 10.28982/josam.1049310 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  17. Psychological impacts of COVID-19 pandemic in cancer patients on active treatment

    Heliyon, 2022

    DOI 10.1016/j.heliyon.2022.e10142 PMID 35996550 8 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  18. Evaluation of LIPI and mGPS as prognostic factors in extensive-stage small-cell lung cancer

    Journal of Surgery and Medicine, 2022

    DOI 10.28982/josam.990665 Frei zugänglicher VolltextQuelle: OpenAlex

  19. Protective Effects of Silymarin on Acetaminophen-Induced Toxic Hepatitis

    Eurasian Journal of Medical Advances, 2022

    DOI 10.14744/ejma.2022.32042 3 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  20. Impact of Breast Cancer Subtypes on Pathological Complete Response Following Neoadjuvant Chemotherapy

    Eurasian Journal of Medical Investigation, 2022

    DOI 10.14744/ejmi.2022.84390 Quelle: OpenAlex

  21. Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study

    Tumori Journal, 2021

    DOI 10.1177/03008916211037739 PMID 34365852 5 Zitationen (Europe PMC) Quelle: OpenAlex

  22. Prognostic Factors in Resected Biliary Tract Cancers and the Impact of Cytokeratin 20 Expression

    Journal of Oncological Sciences, 2021

    DOI 10.37047/jos.2021-84414 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  23. Prognostic factors of ado-trastuzumab emtansine treatment in patients with metastatic HER-2 positive breast cancer

    Journal of Oncology Pharmacy Practice, 2021

    DOI 10.1177/1078155220924088 PMID 32423326 8 Zitationen (Europe PMC) Quelle: ORCID

  24. Efficacy of abiraterone acetate in castration‐resistant metastatic prostate cancer: A real‐world data analysis

    Asia-Pacific Journal of Clinical Oncology, 2021

    DOI 10.1111/ajco.13426 PMID 32892496 4 Zitationen (Europe PMC) Quelle: ORCID

  25. Association of Illness Perception with Chemotherapy-Induced Nausea and Vomiting: A Turkish Oncology Group (TOG) Study

    Future Oncology, 2021

    DOI 10.2217/fon-2020-0939 PMID 33599548 3 Zitationen (OpenAlex) Quelle: OpenAlex

  26. Primary Signet-ring Cell Carcinoma of Colorectal Origin: A Poor Prognostic Entity

    Eurasian Journal of Medical Investigation, 2021

    DOI 10.14744/ejmi.2021.21400 1 Zitation (OpenAlex) Quelle: OpenAlex

  27. EGFR/HER Blokajı Yapan Monoklonal Antikor Ajanlar (Setuksimab, Panitumumab, Trastuzumab, Pertuzumab, Nimotuzumab, Matuzumab)

    Turkiye Klinikleri Medical Oncology - Special Topics, 2021

    Quelle: OpenAlex

  28. PTK-7 Expression in Gastric Cancer: A Prognostic Determinant

    Balkan medical journal, 2020

    DOI 10.4274/balkanmedj.galenos.2019.2019.8.12 PMID 31820857 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: Europe PMC

  29. Characteristics and Clinical Outcome of pT1a-b Node-Negative Breast Cancer

    Northern Clinics of Istanbul, 2020

    DOI 10.14744/nci.2020.06332 PMID 33851075 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  30. Clinical Outcomes of Kaposi’s Sarcoma Treated with Systemic Chemotherapy

    Eurasian Journal of Medical Investigation, 2020

    DOI 10.14744/ejmi.2020.96330 1 Zitation (OpenAlex) Quelle: OpenAlex

  31. Evaluation of Bevacizumab in Advanced Small Bowel Adenocarcinoma

    Clinical Colorectal Cancer, 2016

    DOI 10.1016/j.clcc.2016.04.013 PMID 27247089 17 Zitationen (Europe PMC) Quelle: OpenAlex

  32. The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients

    Clinical & Translational Oncology, 2015

    DOI 10.1007/s12094-015-1408-6 PMID 26459249 3 Zitationen (OpenAlex) Quelle: OpenAlex